Verify patient identity and coagulation profile (INR/platelets). Confirm informed consent. Ensure NPO status for at least 6 hours if possible. Establish intravenous access. Prepare endoscopic trolley with injection catheters and 1:10,000 epinephrine solution.
Monitor vital signs post-procedure in the recovery area. Resume oral intake once sedation effects have dissipated. Provide discharge instructions regarding warning signs such as hematemesis or melena. Follow up with the gastroenterologist within 48 hours for clinical review.
Comprehensive Clinical Guide: Endoscopic Hemostasis via Epinephrine Injection
1. Introduction and Overview
Endoscopic hemostasis via epinephrine injection represents a foundational technique in interventional gastroenterology. Since its introduction, it has remained the "first-line" therapeutic intervention for the management of non-variceal upper gastrointestinal (GI) bleeding. The procedure involves the submucosal or perivascular injection of a dilute epinephrine solution (typically 1:10,000 or 1:20,000) into the site of active hemorrhage or a high-risk stigmata lesion.
The primary objective is to achieve immediate cessation of bleeding through a combination of mechanical tamponade (the volume effect of the injectate) and pharmacological vasoconstriction. While newer technologies such as Hemospray or advanced clipping devices have emerged, the accessibility, cost-effectiveness, and technical simplicity of epinephrine injection ensure it remains a cornerstone of acute GI bleed management.
2. Technical Specifications and Mechanisms of Action
The efficacy of epinephrine injection relies on a dual-mechanism approach that addresses both the physical and physiological aspects of the bleeding vessel.
The Mechanism of Action
- Mechanical Tamponade: The injection of 1–2 mL aliquots of saline/epinephrine creates a "cushion" in the submucosal layer. This volume effect compresses the underlying vessels, slowing the flow and facilitating clot formation.
- Vasoconstriction: Epinephrine is a potent alpha-adrenergic agonist. When injected directly into the perivascular space, it induces profound local vasoconstriction of the arterioles and capillaries. This reduces blood flow to the site, allowing for platelet aggregation and the stabilization of a fibrin clot.
- Secondary Effects: By reducing the local blood flow, the procedure provides the endoscopist with a clearer visual field, which is critical if further definitive therapy (such as thermal coagulation or mechanical clipping) is required.
Pharmacological Preparation
| Component | Concentration | Purpose |
|---|---|---|
| Epinephrine | 1:10,000 or 1:20,000 | Potent vasoconstrictor |
| Normal Saline | Vehicle | Diluent/Volume expansion |
| Total Volume | 1–20 mL (Variable) | Submucosal elevation |
3. Extensive Clinical Indications and Usage
Epinephrine injection is indicated for lesions classified under the Forrest Classification system, specifically those with high-risk stigmata.
Clinical Indications
- Forrest Ia: Spurting arterial hemorrhage.
- Forrest Ib: Oozing hemorrhage.
- Forrest IIa: Visible vessel (non-bleeding but high risk of rebleeding).
- Forrest IIb: Adherent clot (following irrigation and assessment).
Pre-Operative Preparation
- Patient Stabilization: Resuscitation with intravenous fluids and, if necessary, blood products is mandatory before endoscopic intervention.
- Informed Consent: Discussion of the risks of perforation, rebleeding, and cardiovascular side effects (tachycardia).
- Anticoagulation/Antiplatelet Review: While acute bleeding often necessitates reversal, the risk-benefit profile must be assessed.
- Sedation: Standard conscious sedation or monitored anesthesia care (MAC) with propofol, depending on patient stability and institutional protocol.
- Equipment: Injection catheter (typically 23-gauge needle), endoscopic pump or manual syringe, and high-definition endoscope.
4. The Procedure: A Step-by-Step Protocol
Step 1: Identification and Irrigation
The lesion must be thoroughly irrigated with water or saline to clear debris and blood clots. This reveals the true source of the hemorrhage.
Step 2: Catheter Positioning
The injection catheter is passed through the working channel of the endoscope. The needle is kept retracted during insertion to prevent damage to the scope.
Step 3: The Injection Technique
- Targeting: The needle is inserted into the submucosa at the four quadrants surrounding the bleeding vessel.
- The "Squirt" Method: 1–2 mL of epinephrine solution is injected per site.
- Volume: The total volume should be limited to avoid excessive tissue distortion or potential ischemic necrosis.
Step 4: Assessment of Hemostasis
Once the injection is complete, the endoscopist observes for the cessation of flow. If the bleeding persists, a secondary modality (e.g., bipolar cautery or mechanical clips) must be applied immediately, as epinephrine injection is rarely curative as a standalone treatment for severe arterial bleeding.
5. Post-Operative Recovery and Monitoring
Post-procedural management is critical to prevent recurrence.
- Observation: Patients should be monitored in a high-dependency unit or step-down unit for 24–48 hours.
- Pharmacotherapy: Initiation of high-dose intravenous Proton Pump Inhibitors (PPIs) is standard for peptic ulcer bleeding to stabilize the clot by maintaining an intragastric pH > 6.0.
- Dietary Status: NPO (nothing by mouth) for several hours post-procedure, followed by a gradual transition to a clear liquid diet as tolerated.
- Repeat Endoscopy: Generally not required unless clinical evidence of rebleeding (melena, hematemesis, hemodynamic instability) occurs.
6. Risks, Side Effects, and Contraindications
Risks and Complications
- Rebleeding: Epinephrine provides only a temporary "bridge" to hemostasis. Rebleeding rates can reach 15–20% if not followed by thermal or mechanical therapy.
- Tissue Necrosis: Excessive volume or concentration can cause focal ischemia.
- Systemic Cardiovascular Effects: Tachycardia, hypertension, or arrhythmia (rare, usually in patients with underlying cardiac disease).
- Perforation: Deep injection into the muscularis propria or excessive pressure can lead to wall perforation.
Contraindications
- Absolute: Known hypersensitivity to epinephrine (exceedingly rare).
- Relative: Severe uncontrolled hypertension, unstable angina, or uncontrolled tachyarrhythmias (where the systemic effects of epinephrine might be hazardous).
7. Alternative Treatments
While epinephrine is a primary tool, it is often used in combination with:
1. Mechanical Hemostasis: Hemoclips (the gold standard for visible vessels).
2. Thermal Coagulation: Bipolar electrocoagulation (Gold Probe) or Heater Probe.
3. Topical Agents: Hemospray or fibrin glues for diffuse bleeding.
4. Angiographic Embolization: Indicated when endoscopic therapy fails.
5. Surgical Intervention: The final resort for refractory bleeding or perforation.
8. Frequently Asked Questions (FAQ)
1. Is epinephrine injection curative for all GI bleeds?
No. It is considered a "bridge" therapy. It should almost always be combined with a secondary modality like clipping or cautery to ensure durable hemostasis.
2. What is the standard dilution ratio?
The most common ratio is 1:10,000, though 1:20,000 is often used to minimize systemic cardiovascular side effects.
3. How much volume should be injected?
Typically, 1–2 mL per quadrant (4–8 mL total). Excessive volume can cause tissue damage.
4. Can epinephrine be used for esophageal varices?
No. Epinephrine is contraindicated for varices as it does not address the underlying portal hypertension and may cause tissue sloughing. Band ligation or sclerotherapy is required.
5. What are the signs of systemic epinephrine absorption?
Patients may experience palpitations, transient hypertension, or sudden anxiety. These symptoms usually resolve spontaneously within minutes.
6. Why is a PPI administered after the procedure?
PPIs neutralize gastric acid, which otherwise would dissolve the fibrin clot that is essential for long-term healing of the ulcer base.
7. What is the risk of perforation with this procedure?
The risk is very low (<1%) when performed by an experienced endoscopist using proper submucosal technique.
8. Does the needle size matter?
Yes. A 23-gauge needle is standard. Smaller needles (25-gauge) may be used for finer control, but larger needles provide better flow for high-volume injection.
9. What should I do if the bleeding does not stop after epinephrine?
Do not continue injecting epinephrine. Switch to a mechanical modality like hemoclips or thermal coagulation immediately.
10. How long does the vasoconstrictive effect last?
The effect is transient, typically lasting 15 to 30 minutes, which is why secondary therapy is mandatory for high-risk lesions.
9. Conclusion
Endoscopic epinephrine injection remains an indispensable skill for the interventional endoscopist. By understanding the mechanism—a combination of mechanical compression and adrenergic vasoconstriction—clinicians can effectively stabilize hemorrhaging patients, providing the necessary window to implement definitive, long-term therapeutic measures. While the procedure is straightforward, its success is highly dependent on operator precision, appropriate patient selection, and the integration of adjunctive therapies. Adherence to these clinical guidelines ensures optimal patient outcomes and minimizes the risk of treatment failure.